Disease/Infection News

RSS

A protein in the lung forms a natural protective barrier against SARS-CoV-2 infection

University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and forms a natural protective barrier in the human body.

10 Feb 2023

Novel compound curtails influenza virus replication

Viruses use the molecular repertoire of the host cell to replicate. Researchers from the Cluster of Excellence ImmunoSensation2 at the University of Bonn, together with Japanese researchers, want to exploit this for the treatment of influenza.

10 Feb 2023

Psychological trauma related to HIV could make it difficult to end the AIDS epidemic

Failing to address the psychological trauma experienced by many older people living with HIV/AIDS will make it difficult, if not impossible, to end the epidemic, according to a Rutgers study.

8 Feb 2023

Microbiome therapeutic linked to quality of life improvement in patients with recurrent C. diff infection

Kevin Garey, professor of pharmacy practice and translational research at the University of Houston College of Pharmacy is reporting the first well-controlled study to demonstrate that a microbiome therapeutic, SER-109, is associated with significant quality of life improvement in patients with the debilitating recurrent infection and disease caused by Clostridium difficile (or C. diff).

1 Feb 2023

UNC research describes another layer to the challenge of HIV latency

When people living with HIV take antiviral therapy (ART), their viral loads are driven so low that a standard blood test cannot detect the virus.

1 Feb 2023

Genomic study helps retrace origin and spread of Shigellosis outbreak in Seattle

A genomic study of a sustained, multidrug-resistant Shigellosis outbreak in Seattle enabled scientists to retrace its origin and spread.

1 Feb 2023

Research supports the safety and efficacy of COVID-19 vaccination in cancer patients receiving immunotherapy

Research findings published in Frontiers in Immunology show that cancer immunotherapy does not interfere with COVID-19 immunity in previously vaccinated patients.

1 Feb 2023

The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

...

From The Native Antigen Company 8 Dec 2022

New framework for developing ecological countermeasures to prevent pandemics

Preserving and restoring natural habitats could prevent pathogens that originate in wildlife from spilling over into domesticated animals and humans, according to two new companion studies.

17 Nov 2022

Unraveling sex determination in Bursaphelenchus nematodes: A path towards pest-control

The mechanisms underlying sex determination in nematodes, commonly known as roundworms, have not been fully understood.

23 Jun 2022

New chemical-only process may represent an important breakthrough in creating customized mRNA vaccines

At the Nagoya University in Japan, scientists have come up with a new chemical-only process that might signify an essential discovery in making tailored mRNA vaccines for a range of diseases and enable the low-cost making of mRNA in large quantities.

9 Jun 2022

Researchers develop advanced machine learning to count blood cells

The use of machine learning to do blood cell counts for illness detection rather than costly and often less reliable cell analyzer devices has proven labor-intensive, as the training of the machine learning model requires a tremendous amount of manual annotation activity by humans.

27 May 2022

bit.bio launches Huntington’s disease human cell model

First neurodegenerative disease model launched from bit.bio's new ioDisease Model portfolio.

From bit.bio 10 May 2022

Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

...

From Dotmatics 5 May 2022

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Combining Alamar's Attobody™ platform with Mologic's RDTs, this collaboration focuses on developing highly sensitive COVID-19 tests for global health readiness.

5 May 2022

Releasing Wolbachia-infected mosquitoes to protect the global community from dengue

Dengue is the most widespread mosquito-borne disease in the world, and to date, there are no medical treatments for people suffering from this disease.

21 Apr 2022

Discovery could help break the cycle of rapid transmission of TB

Two strains of the bacterium causing tuberculosis have only minor genetic differences but attack the lungs in completely different fashion, according to Rutgers researchers.

18 Apr 2022

Proteins in saliva could serve as a biomarker to identify patients at risk for severe COVID-19

Researchers have identified a family of proteins that is significantly elevated in the saliva of patients hospitalized with COVID-19.

5 Apr 2022

Multiple nanobodies effectively block infection with different SARS-CoV-2 variants

Researchers at Karolinska Institutet in Sweden have developed a novel strategy for identifying potent miniature antibodies, so-called nanobodies, against emerging SARS-CoV-2 variants.

28 Mar 2022

Study reveals why infected individuals cannot get rid of HIV altogether

Thanks to antiretroviral therapy, HIV infection is no longer the life sentence it once was. But despite the effectiveness of drugs to manage and treat the virus, it can never be fully eliminated from the human body, lingering in some cells deep in different human tissues where it goes unnoticed by the immune system.

28 Mar 2022

Disease/Infection News

A protein in the lung forms a natural protective barrier against SARS-CoV-2 infection

Novel compound curtails influenza virus replication

Psychological trauma related to HIV could make it difficult to end the AIDS epidemic

Microbiome therapeutic linked to quality of life improvement in patients with recurrent C. diff infection

UNC research describes another layer to the challenge of HIV latency

Genomic study helps retrace origin and spread of Shigellosis outbreak in Seattle

Research supports the safety and efficacy of COVID-19 vaccination in cancer patients receiving immunotherapy

The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

New framework for developing ecological countermeasures to prevent pandemics

Unraveling sex determination in Bursaphelenchus nematodes: A path towards pest-control

New chemical-only process may represent an important breakthrough in creating customized mRNA vaccines

Researchers develop advanced machine learning to count blood cells

bit.bio launches Huntington’s disease human cell model

Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Releasing Wolbachia-infected mosquitoes to protect the global community from dengue

Discovery could help break the cycle of rapid transmission of TB

Proteins in saliva could serve as a biomarker to identify patients at risk for severe COVID-19

Multiple nanobodies effectively block infection with different SARS-CoV-2 variants

Study reveals why infected individuals cannot get rid of HIV altogether

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics